Latest filing published 18 Aug 2020 for Navidea Biopharmaceuticals, INC..
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Jed Latkin: trading record in brief
Jed Latkin is a declared insider of Navidea Biopharmaceuticals, Inc., with filings sourced from SEC (Form 4). The record holds 14 filings, for trades running from 17 May 2017 to 14 August 2020.
Purchases make up the whole of the open-market record (10 purchases, €31k). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 4 share grants. So far in 2020, the count stands at 1 purchase and no sales.
Half of the purchases are above €3,127 and half below. Clusters matter here: 7 out of 10 purchases overlapped with buying by a colleague within 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.
On 18 August 2020 came the latest disclosure, a share grant in Navidea Biopharmaceuticals, Inc. The last purchase on record was published on 20 February 2020, which is 2,454 days ago. Typically, a trade is published a median of 1 day after it takes place. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Jed Latkin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 50,000 shares0Common StockSEC:0001437749-20-018294:0
- 33,997 shares@ US$2.6294.1% of flowCommon StockSEC:0001437749-20-012480:0
- 5,000 shares@ US$1.085.9% of flowCommon StockSEC:0001437749-20-003172:0Canonical exit: 20 May 2020 (T+90)
- 1,000 shares@ US$1.261.1% of flowCommon StockSEC:0001437749-19-011608:0Canonical exit: 3 Sept 2019 (T+90)
- 1,500 shares@ US$1.452.0% of flowCommon StockSEC:0001437749-19-010383:0Canonical exit: 14 Aug 2019 (T+90)
- 1,000 shares@ US$1.461.3% of flowCommon StockSEC:0001437749-19-010383:1Canonical exit: 15 Aug 2019 (T+90)
- 2,400 shares@ US$1.914.2% of flowCommon StockSEC:0001437749-19-010054:0Canonical exit: 11 Aug 2019 (T+90)
- 2,000 shares@ US$1.843.4% of flowCommon StockSEC:0001437749-19-010054:1Canonical exit: 12 Aug 2019 (T+90)
- 1,000 shares@ US$1.451.3% of flowCommon StockSEC:0001437749-19-010054:2Canonical exit: 13 Aug 2019 (T+90)
- 7,600 shares@ US$0.43642.5% of flowCommon Stock, $.001 par valueSEC:0001654954-17-005235:0Canonical exit: 28 Aug 2017 (T+90)
- 14,159 shares@ US$0.45114.9% of flowCommon Stock, $.001 par valueSEC:0001654954-17-005032:0Canonical exit: 17 Aug 2017 (T+90)
- 11,200 shares@ US$0.44993.8% of flowCommon Stock, $.001 par valueSEC:0001654954-17-005032:1Canonical exit: 20 Aug 2017 (T+90)
- 13,300 shares@ US$0.4674.7% of flowCommon Stock, $.001 par valueSEC:0001654954-17-004944:0
- 3,900 shares@ US$0.44961.3% of flowCommon Stock, $.001 par valueSEC:0001654954-17-004944:1
14 of 14 declarations